GlaxoSmithKline: Mepolizumab recommended for approval in Europe

NEUTRAL, Fair Value 1520p vs. 1470p (+21%)
News published on September Friday 25, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities